Lista de obras - Serenella M Pupa - Dominio Público Uruguay

Activated d16HER2 homodimers and SRC kinase mediate optimal efficacy for trastuzumab

artículo científico publicado en 2014

Activation of mononuclear cells to be used for hybrid monoclonal antibody-induced lysis of human ovarian carcinoma cells

artículo científico publicado en 1988

Activity and resistance of trastuzumab according to different clinical settings.

artículo científico publicado en 2011

An in vivo model to compare human leukocyte infiltration in carcinoma xenografts producing different chemokines.

artículo científico publicado en 1995

Anti-ovarian carcinoma anti-T3 heteroconjugates or hybrid antibodies induce tumor cell lysis by cytotoxic T-cells.

artículo científico publicado en 1988

Apoptosis induction by trastuzumab: possible role of the core biopsy intervention

artículo científico publicado en 2005

Biomarkers of Primary Resistance to Trastuzumab in HER2-Positive Metastatic Gastric Cancer Patients: the AMNESIA Case-Control Study.

artículo científico publicado en 2017

Cancer Stem Cells: Devil or Savior-Looking behind the Scenes of Immunotherapy Failure

artículo científico publicado en 2020

Characterization of human ovarian carcinoma-associated antigens defined by novel monoclonal antibodies with tumor-restricted specificity.

artículo científico publicado en 1987

Curability of advanced Burkitt's lymphoma in children by intensive short-term chemotherapy

artículo científico publicado en 1993

Distinct pattern of HSP72 and monomeric laminin receptor expression in human lung cancers infiltrated by γ/δ T lymphocytes

scientific article published on 01 May 1994

Electroporated DNA vaccine clears away multifocal mammary carcinomas in her-2/neu transgenic mice.

artículo científico publicado en 2004

HER-2: a biomarker at the crossroads of breast cancer immunotherapy and molecular medicine.

artículo científico publicado en 2005

HER2 as a target for breast cancer therapy.

artículo científico publicado en 2010

HSPH1 inhibition downregulates Bcl-6 and c-Myc and hampers the growth of human aggressive B-cell non-Hodgkin lymphoma.

artículo científico publicado en 2015

Human ovarian carcinoma lysis by cytotoxic t cells targeted by bispecific monoclonal antibodies: Analysis of the antibody components

article

Humoral immune response for early diagnosis of breast carcinoma

artículo científico publicado en 2002

Identification of relevant conformational epitopes on the HER2 oncoprotein by using Large Fragment Phage Display (LFPD).

artículo científico publicado en 2013

Immunological and pathobiological roles of fibulin-1 in breast cancer.

artículo científico publicado en 2004

Impact of systemic and tumor lipid metabolism on everolimus efficacy in advanced pancreatic neuroendocrine tumors (pNETs)

scientific article published on 07 January 2019

Improved clinical outcome in indolent B-cell lymphoma patients vaccinated with autologous tumor cells experiencing immunogenic death.

artículo científico publicado en 2010

Increased overall survival independent of RECIST response in metastatic breast cancer patients continuing trastuzumab treatment: evidence from a retrospective study.

artículo científico publicado en 2011

Inhibition of the Wnt Signalling Pathway: An Avenue to Control Breast Cancer Aggressiveness

scientific article published on 28 November 2020

Innovative Therapy, Monoclonal Antibodies and Beyond.

artículo científico publicado en 2017

Innovative therapy, monoclonal antibodies, and beyond: Highlights from the eighth annual meeting

artículo científico publicado en 2018

Intratumor lactate levels reflect HER2 addiction status in HER2-positive breast cancer

artículo científico publicado en 2018

Monoclonal antibody to fibulin-1 generated by genetic immunization.

artículo científico publicado en 2003

New basic discoveries and frontiers in diagnosis, prognosis and prediction of response to therapy in human thyroid, urinary bladder, and prostate tumors.

artículo científico publicado en 2004

New insights into the role of extracellular matrix during tumor onset and progression.

artículo científico publicado en 2002

Pathobiological implications of the d16HER2 splice variant for stemness and aggressiveness of HER2-positive breast cancer

artículo científico publicado en 2016

Phenethyl isothiocyanate hampers growth and progression of HER2-positive breast and ovarian carcinoma by targeting their stem cell compartment

artículo científico publicado en 2019

Potential role of HER2-overexpressing exosomes in countering trastuzumab-based therapy

artículo científico publicado en 2012

Prevention of spontaneous neu-expressing mammary tumor development in mice transgenic for rat proto-neu by DNA vaccination.

artículo científico publicado en 2001

Promise and failure of targeted therapy in breast cancer

artículo científico

Purification of immunoreactive radiolabeled monoclonal antibodies with anti-idiotypic monoclonal antibodies

scientific article published on 01 February 1990

RET fusions in a small subset of advanced colorectal cancers at risk of being neglected.

artículo científico publicado en 2018

SEL1L a multifaceted protein playing a role in tumor progression.

artículo científico publicado en 2006

Shed HER2 extracellular domain in HER2-mediated tumor growth and in trastuzumab susceptibility

artículo científico publicado en 2010

Synergistic Activation upon MET and ALK Coamplification Sustains Targeted Therapy in Sarcomatoid Carcinoma, a Deadly Subtype of Lung Cancer

artículo científico publicado en 2016

The 67 kDa laminin receptor increases tumor aggressiveness by remodeling laminin-1.

artículo científico publicado en 2005

The HER2 World: Better Treatment Selection for Better Outcome

artículo científico publicado en 2011

The d16HER2 Splice Variant: A Friend or Foe of HER2-Positive Cancers?

scientific article published on 28 June 2019

The human splice variant Δ16HER2 induces rapid tumor onset in a reporter transgenic mouse.

artículo científico publicado en 2011

The landscape of d16HER2 splice variant expression across HER2-positive cancers

artículo científico publicado en 2019

Vaccination with autologous tumor-loaded dendritic cells induces clinical and immunologic responses in indolent B-cell lymphoma patients with relapsed and measurable disease: a pilot study.

artículo científico publicado en 2008

WNT signaling modulates PD-L1 expression in the stem cell compartment of triple-negative breast cancer

scientific article published on 31 January 2019

Lista de obras de Serenella M Pupa

Activated d16HER2 homodimers and SRC kinase mediate optimal efficacy for trastuzumab

Activation of mononuclear cells to be used for hybrid monoclonal antibody-induced lysis of human ovarian carcinoma cells

Activity and resistance of trastuzumab according to different clinical settings.

An in vivo model to compare human leukocyte infiltration in carcinoma xenografts producing different chemokines.

Anti-ovarian carcinoma anti-T3 heteroconjugates or hybrid antibodies induce tumor cell lysis by cytotoxic T-cells.

Apoptosis induction by trastuzumab: possible role of the core biopsy intervention

Biomarkers of Primary Resistance to Trastuzumab in HER2-Positive Metastatic Gastric Cancer Patients: the AMNESIA Case-Control Study.

Cancer Stem Cells: Devil or Savior-Looking behind the Scenes of Immunotherapy Failure

Characterization of human ovarian carcinoma-associated antigens defined by novel monoclonal antibodies with tumor-restricted specificity.

Curability of advanced Burkitt's lymphoma in children by intensive short-term chemotherapy

Distinct pattern of HSP72 and monomeric laminin receptor expression in human lung cancers infiltrated by γ/δ T lymphocytes

Electroporated DNA vaccine clears away multifocal mammary carcinomas in her-2/neu transgenic mice.

HER-2: a biomarker at the crossroads of breast cancer immunotherapy and molecular medicine.

HER2 as a target for breast cancer therapy.

HSPH1 inhibition downregulates Bcl-6 and c-Myc and hampers the growth of human aggressive B-cell non-Hodgkin lymphoma.

Human ovarian carcinoma lysis by cytotoxic t cells targeted by bispecific monoclonal antibodies: Analysis of the antibody components

Humoral immune response for early diagnosis of breast carcinoma

Identification of relevant conformational epitopes on the HER2 oncoprotein by using Large Fragment Phage Display (LFPD).

Immunological and pathobiological roles of fibulin-1 in breast cancer.

Impact of systemic and tumor lipid metabolism on everolimus efficacy in advanced pancreatic neuroendocrine tumors (pNETs)

Improved clinical outcome in indolent B-cell lymphoma patients vaccinated with autologous tumor cells experiencing immunogenic death.

Increased overall survival independent of RECIST response in metastatic breast cancer patients continuing trastuzumab treatment: evidence from a retrospective study.

Inhibition of the Wnt Signalling Pathway: An Avenue to Control Breast Cancer Aggressiveness

Innovative Therapy, Monoclonal Antibodies and Beyond.

Innovative therapy, monoclonal antibodies, and beyond: Highlights from the eighth annual meeting

Intratumor lactate levels reflect HER2 addiction status in HER2-positive breast cancer

Monoclonal antibody to fibulin-1 generated by genetic immunization.

New basic discoveries and frontiers in diagnosis, prognosis and prediction of response to therapy in human thyroid, urinary bladder, and prostate tumors.

New insights into the role of extracellular matrix during tumor onset and progression.

Pathobiological implications of the d16HER2 splice variant for stemness and aggressiveness of HER2-positive breast cancer

Phenethyl isothiocyanate hampers growth and progression of HER2-positive breast and ovarian carcinoma by targeting their stem cell compartment

Potential role of HER2-overexpressing exosomes in countering trastuzumab-based therapy

Prevention of spontaneous neu-expressing mammary tumor development in mice transgenic for rat proto-neu by DNA vaccination.

Promise and failure of targeted therapy in breast cancer

Purification of immunoreactive radiolabeled monoclonal antibodies with anti-idiotypic monoclonal antibodies

RET fusions in a small subset of advanced colorectal cancers at risk of being neglected.

SEL1L a multifaceted protein playing a role in tumor progression.

Shed HER2 extracellular domain in HER2-mediated tumor growth and in trastuzumab susceptibility

Synergistic Activation upon MET and ALK Coamplification Sustains Targeted Therapy in Sarcomatoid Carcinoma, a Deadly Subtype of Lung Cancer

The 67 kDa laminin receptor increases tumor aggressiveness by remodeling laminin-1.

The HER2 World: Better Treatment Selection for Better Outcome

The d16HER2 Splice Variant: A Friend or Foe of HER2-Positive Cancers?

The human splice variant Δ16HER2 induces rapid tumor onset in a reporter transgenic mouse.

The landscape of d16HER2 splice variant expression across HER2-positive cancers

Vaccination with autologous tumor-loaded dendritic cells induces clinical and immunologic responses in indolent B-cell lymphoma patients with relapsed and measurable disease: a pilot study.

WNT signaling modulates PD-L1 expression in the stem cell compartment of triple-negative breast cancer